Open Access

MicroRNA‑1236‑3p/translationally controlled tumor protein (TPT1) axis participates in congenital hypothyroidism progression by regulating neuronal apoptosis

  • Authors:
    • Tingting Meng
    • Shiman Shen
    • Cheng Li
    • Xuehua Liu
  • View Affiliations

  • Published online on: November 29, 2019     https://doi.org/10.3892/etm.2019.8262
  • Pages: 459-466
  • Copyright: © Meng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Congenital hypothyroidism (CH) is an endocrine disease caused by congenital thyroid hormone (TH) deficiency. MicroRNAs (miRNAs or miRs) have been reported to inhibit the progression of congenital hypothyroidism. However, the expression and role of miR‑1236‑3p in CH remains unclear. To address this, 12 day old Sprague‑Dawley rats were divided into five groups: Control; Congenital hypothyroidism (CH), miR‑1236‑3p inhibitor control (inhibitor control); miR‑1236‑3p inhibitor (inhibitor); and miR‑1236‑3p inhibitor + translationally‑controlled tumor protein 1 (TPT1)‑small interfering (si)RNA (inhibitor + siRNA). Propylthiouracil (50 mg/day) was injected intraperitoneally into pregnant rats to generate pups with CH. The levels of miR‑1236‑3p and TPT1 were detected via reverse transcription‑quantitative PCR and western blot analysis. Bioinformatics analysis was performed to predict the targets of miR‑1236‑3p, which was confirmed using dual luciferase reporter assay. Flow cytometry and MTT assay were used to measure neuronal cell apoptosis and cell viability, whereas western blotting was applied to detect the expression of Pim‑3, p‑Bad (Ser112), Bad and Bcl‑xL, proteins associated with apoptosis. The results revealed that miR‑1236‑3p expression was significantly upregulated, whilst TPT1 expression was significantly downregulated in the hippocampus tissues of CH rats compared with the control group. TPT1 was confirmed as a target of miR‑1236‑3p. MiR‑1236‑3p inhibitor prevented hippocampal neuron apoptosis induced by CH induction, which was reversed by TPT1‑siRNA transfection. In addition, following miR‑1236‑3p inhibitor transfection, neuronal cell apoptosis significantly reduced compared with the control group, which was accompanied by significantly increased expressions of Pim‑3, p‑Bad (Ser112) and Bcl‑xL expression. These effects were reversed by TPT1‑siRNA co‑transfection. These results indicated that inhibition of miR‑1236‑3p expression inhibited neuron apoptosis in vivo and in vitro by targeting TPT1, serving a protective role in CH.
View Figures
View References

Related Articles

Journal Cover

January-2020
Volume 19 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Meng T, Shen S, Li C and Liu X: MicroRNA‑1236‑3p/translationally controlled tumor protein (TPT1) axis participates in congenital hypothyroidism progression by regulating neuronal apoptosis. Exp Ther Med 19: 459-466, 2020
APA
Meng, T., Shen, S., Li, C., & Liu, X. (2020). MicroRNA‑1236‑3p/translationally controlled tumor protein (TPT1) axis participates in congenital hypothyroidism progression by regulating neuronal apoptosis. Experimental and Therapeutic Medicine, 19, 459-466. https://doi.org/10.3892/etm.2019.8262
MLA
Meng, T., Shen, S., Li, C., Liu, X."MicroRNA‑1236‑3p/translationally controlled tumor protein (TPT1) axis participates in congenital hypothyroidism progression by regulating neuronal apoptosis". Experimental and Therapeutic Medicine 19.1 (2020): 459-466.
Chicago
Meng, T., Shen, S., Li, C., Liu, X."MicroRNA‑1236‑3p/translationally controlled tumor protein (TPT1) axis participates in congenital hypothyroidism progression by regulating neuronal apoptosis". Experimental and Therapeutic Medicine 19, no. 1 (2020): 459-466. https://doi.org/10.3892/etm.2019.8262